VistaGen Therapeutics, Inc. earnings per share and revenue

VTGN earnings per share for the last quarter are -0.22 USD whereas the estimation was -0.30 USD which accounts for 27.27% surprise. Company revenue for the same period amounts to 411.40 k USD despite the estimated figure of 726.00 k USD. Estimated earnings per share for the next quarter are -0.36 USD, and revenue is expected to reach 405.70 k USD. Also watch annual changes over time to get a bigger picture of VTGN earnings per share and revenue dynamics.